Carlo Bevans
liked and commented on
$Zoom Communications (ZM.US)$ I'll never understand why Zoom got so big in the first place , what moat does a simple program like a video conference app even have ?
"hurr durr the quality" sure whatever ,I really need to see the lame powerpoint presentation from work in 4k . Not.
"hurr durr the quality" sure whatever ,I really need to see the lame powerpoint presentation from work in 4k . Not.
9
1
Carlo Bevans
liked
$Moderna (MRNA.US)$ Karma for Moderna for the CEO's idiotic and unfounded comments yesterday about omicron virus not effective through existing vaccines, information that has not backup and rattled the overall markets in the early morning hours. Some CEO's are out only to falsify information to protect their products and share. Fraud and immoral.
14
4
Carlo Bevans
liked and commented on
$General Motors (GM.US)$ With good earnings while pushing for EV future, GM is a no brainer. Much safer compared to any other EV companies. Never interested in GM vehicles until Lyriq...
15
1
Carlo Bevans
liked
$Moderna (MRNA.US)$ The vaccines are NOT vaccines- they are gene therapies. Even Dr. Fraudci would have to admit that point. Real vaccines take years to develop and test.
16
5
Carlo Bevans
liked and commented on
A federal appeals court has upheld a ruling by the U.S. Patent and Trademark Office to not invalidate patents held by $Arbutus Biopharma (ABUS.US)$, dealing a blow to $Moderna (MRNA.US)$.
The court ruled that Moderna had no standing to appeal.
The patents in question cover a novel lipid formulation for nucleic acid delivery. These lipid nanoparticles are essential to protect mRNA therapies as they travel through the body to cells.
As a result, Arbutus may be eligible for royalties from Moderna from sales of its COVID-19 vaccine.
Moderna had argued that the claims in the patents were obvious and upholding them would open the company to patent infringement lawsuits.
The court ruled that Moderna had no standing to appeal.
The patents in question cover a novel lipid formulation for nucleic acid delivery. These lipid nanoparticles are essential to protect mRNA therapies as they travel through the body to cells.
As a result, Arbutus may be eligible for royalties from Moderna from sales of its COVID-19 vaccine.
Moderna had argued that the claims in the patents were obvious and upholding them would open the company to patent infringement lawsuits.
23
13
Carlo Bevans
liked and commented on
$Lucid Group (LCID.US)$ I recall Mayor Pete showing up to an event of some sort, stopping his entourage short of the locale, then unloading a bicycle from the back of his Chevy Suburban so he could show up "appearing" to give a shit! Nice try Mayor Pete...
11
1
Carlo Bevans
liked
$Tesla (TSLA.US)$ I can't imagine that Space X employees are all sitting around, jerking off playing video games and watching Karen compilations on youtube all day because they don't have much else to do. His statement was meant for the media, not his staff. His employees being the cream of the crop do not need threats of bankruptcy in order to be productive...lol, jesus christ.
11
2
Carlo Bevans
liked and commented on
$MasterCard (MA.US)$has announced a new share repurchase program to buyback up to $8B of its Class A common stock.
The latest authorization will become effective at the completion of the company's previously announced $6B program. Approximately $4.4B remains outstanding under the current program authorization.
$8B share repurchase authorization represents 2.5% of current market cap of $318.5B.
In other news, Mastercard raised its quarterly dividend by 11% to $0.49.
Shares are +0.66% AH
The latest authorization will become effective at the completion of the company's previously announced $6B program. Approximately $4.4B remains outstanding under the current program authorization.
$8B share repurchase authorization represents 2.5% of current market cap of $318.5B.
In other news, Mastercard raised its quarterly dividend by 11% to $0.49.
Shares are +0.66% AH
20
7
Carlo Bevans
liked and commented on
$Lucid Group (LCID.US)$ What I always struggle with is that a stock price is only "partially" based on absolute valuations.... plus a whole lot of "perceived" value (e.g., meme stocks). Tesla's P/E at one time was over 1000 when the average S&P 500 stock was in the 20s. Its P/E is 368 today and a lot of people still see it as a buy, even with its valuation being more than the top 10 car companies COMBINED! Long on Lucid because of its great tech, excellent management, and future growth plans.
15
2
Carlo Bevans
liked and commented on
$SPDR S&P 500 ETF (SPY.US)$ Keep a cool head, and add shares in your portfolio of companies with top notch fundamentals. Everything else is just noise.
17
5
Carlo Bevans : Respect the PowerPoint Ranger!